Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (3727)	2/4/1998 1:50:00 AM
From: David S.	Read Replies (2) of 6136

"Then why was VRTX done". Can we try for complete thoughts, John? Then I will be able to respond to them, but I do not want to assume what you are trying to communicate. What is also interesting though, caught out of the corner of my eye as I was leaving the coal mine today, is that the notion of unique mutation profiles being so wonderful for a protease inhibitor that you may know of, and of course, ones in the pipeline from other companies - well, it may not be all that's it's been cracked up to be. I'll try to find the thing tomarrow, and give you the direct source, but right now I am home in my jammies so you'll just have to wait. How's the rain in Diego?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next